<DOC>
	<DOCNO>NCT01132703</DOCNO>
	<brief_summary>The primary objective study evaluate safety tolerability RP-1127 ( glyburide injection ) , administer bolus dose follow 3 day continuous infusion . The secondary objective assess pharmacokinetics RP-1127 blood glucose serum insulin PD responses RP-1127 .</brief_summary>
	<brief_title>Safety Study RP-1127 ( Glyburide Injection ) Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Glyburide</mesh_term>
	<criteria>1 . Between 18 55 year age , inclusive . 2 . A healthy male healthy nonpregnant , nonlactating female . 3 . Capable understand comply protocol sign informed consent form Screening procedures begin . 4 . Have body mass index 18.0 30.0 kg/mÂ² , inclusive . 5 . A clinically normal physical examination , 12lead electrocardiogram ( ECG ) , screen laboratory study urinalysis . 6 . A negative urine saliva test select substance abuse cotinine . 1 . Clinically significant history hypoglycemia assess investigator . 2 . History seizure disorder , even currently receive anticonvulsant medication . 3 . History adverse reaction glyburide , sulfonylurea class antidiabetic medication , sulfa drug . 4 . Glucose6phosphate dehydrogenase ( G6PD ) deficiency determine G6PD enzyme test screen . 5 . Be active smoker user form tobacco . Former smoker tobacco user must refrain smoke use form tobacco least 6 month prior dose Study Day 1 . 6 . A history clinical manifestation significant metabolic ( include diabetes mellitus , hypercholesterolemia , dyslipidemia ) , hematologic , pulmonary , cardiovascular , gastrointestinal , neurologic , hepatic , renal , urologic , immunologic , psychiatric disorder ( history mild depression , currently receive therapy , acceptable ) . 7 . Use prescription medication within 14 day prior randomization , nonprescription drug within 7 day . Exceptions may make medical monitor casebycase basis . 8 . Received another investigational drug within 30 day prior randomization . 9 . A positive hepatitis virus test ( Hepatitis B virus surface antigen hepatitis C virus antibody ) positive human immunodeficiency virus ( HIV ) antibody test screening . If HIV test positive , subject inform privately refer additional counseling .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>